Verónica Galván

8.9k total citations · 2 hit papers
93 papers, 6.7k citations indexed

About

Verónica Galván is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Verónica Galván has authored 93 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Physiology, 37 papers in Molecular Biology and 23 papers in Neurology. Recurrent topics in Verónica Galván's work include Alzheimer's disease research and treatments (43 papers), Genetics, Aging, and Longevity in Model Organisms (13 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). Verónica Galván is often cited by papers focused on Alzheimer's disease research and treatments (43 papers), Genetics, Aging, and Longevity in Model Organisms (13 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). Verónica Galván collaborates with scholars based in United States, Hungary and Argentina. Verónica Galván's co-authors include Dale E. Bredesen, Olivia Gorostiza, Bernard Roizman, Zoltán Ungvári, Arlan Richardson, Stefano Tarantini, Anna Csiszár, Matthew J. Hart, Natalia Podlutskaya and Randy Strong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Verónica Galván

92 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

2010 807 citations Patricia Spilman, Natalia Podlutskaya et al. PLoS ONE profile →
Mechanisms of Vascular Aging

2018 613 citations Zoltán Ungvári, Stefano Tarantini et al. profile →

Peers

Countries citing papers authored by Verónica Galván

Since Specialization

Citations

This map shows the geographic impact of Verónica Galván's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Galván with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Galván more than expected).

Fields of papers citing papers by Verónica Galván

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Galván. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Galván. The network helps show where Verónica Galván may publish in the future.

Co-authorship network of co-authors of Verónica Galván

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Galván. A scholar is included among the top collaborators of Verónica Galván based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Galván. Verónica Galván is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice 2023 ·GeroScience ·(unknown), Rong Wang, Zhen Yu, (unknown), (unknown), (unknown), (unknown), Kathy R. Magnusson, Verónica Galván, Viviana Pérez	10
2	Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID-19: Protocol and methodology of a prospective longitudinal observational study 2023 ·PLoS ONE ·Cameron D. Owens, Camila Bonin Pinto, Péter Mukli, Z Szarvas, Anna Péterfi, (unknown), (unknown), Ann Louise Olson, Guangpu Li, Verónica Galván, Angelia Kirkpatrick, Priya Balasubramanian, Stefano Tarantini, Anna Csiszár, Zoltán Ungvári, Călin I. Prodan, Andriy Yabluchanskiy	11
3	Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer’s-like pathology in mouse and fly APP overexpression models 2022 ·Science Advances ·E. Sandra Chocrón, Erin Munkácsy, (unknown), (unknown), (unknown), Candice E. Van Skike, Nicholas DeRosa, (unknown), Juan Pablo Palavicini, Paweł Wityk, Leszek Kalinowski, Verónica Galván, Paweł A. Osmulski, Elżbieta Jankowska, Maria Gaczyńska, Andrew M. Pickering	33
4	Monkeypox: considerations for the understanding and containment of the current outbreak in non-endemic countries 2022 ·GeroScience ·Jorge Quarleri, M. Victoria Delpino, Verónica Galván	84
5	Henipaviruses: an expanding global public health concern? 2022 ·GeroScience ·Jorge Quarleri, Verónica Galván, M. Victoria Delpino	24
6	Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer’s disease-like neuroinflammation and cognitive impairment 2021 ·Molecular Neurodegeneration ·Shulan Qiu, Juan Pablo Palavicini, Jianing Wang, (unknown), Sijia He, (unknown), Cheng Zou, Lin Ding, (unknown), Candice E. Van Skike, Verónica Galván, Jeffrey L. Dupree, Xianlin Han	83
7	In Vivo Generation of Lung and Thyroid Tissues from Embryonic Stem Cells Using Blastocyst Complementation 2020 ·American Journal of Respiratory and Critical Care Medicine ·Bingqiang Wen, (unknown), Vladimir Ustiyan, Guolun Wang, Minzhe Guo, Cheng-Lun Na, (unknown), Verónica Galván, Yan Xu, Timothy E. Weaver, Tanya V. Kalin, Jeffrey A. Whitsett, Vladimir V. Kalinichenko	40
8	Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer’s disease using functional laser speckle contrast imaging 2017 ·GeroScience ·Stefano Tarantini, Gábor Fülöp, Tamás Kiss, Eszter Farkas, (unknown), Verónica Galván, Péter Tóth, Anna Csiszár, Zoltán Ungvári, Andriy Yabluchanskiy	78
9	Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies 2017 ·Aging and Disease ·Diana L. Castillo‐Carranza, Ashley N. Nilson, Candice E. Van Skike, Jordan B. Jahrling, (unknown), (unknown), Julia E. Gerson, Urmi Sengupta, Jose F. Abisambra, Peter T. Nelson, Juan C. Troncoso, Zoltán Ungvári, Verónica Galván, Rakez Kayed	89
10	Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease 2017 ·GeroScience ·Anna Csiszár, Stefano Tarantini, Gábor Fülöp, Tamás Kiss, Marta Noa Valcarcel‐Ares, Verónica Galván, Zoltán Ungvári, Andriy Yabluchanskiy	78
11	Chronic mTOR inhibition in mice with rapamycin alters T , B , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice 2015 ·Aging Cell ·Vincent Hurez, Vinh Dao, Aijie Liu, Srilakshmi Pandeswara, Jonathan Gelfond, Lishi Sun, Molly A. Bergman, Carlos J. Orihuela, Verónica Galván, Álvaro Padrón, Justin Drerup, Yang Liu, Paul Hasty, Z. Dave Sharp, Tyler J. Curiel	98
12	Decreased in vitro Mitochondrial Function is Associated with Enhanced Brain Metabolism, Blood Flow, and Memory in Surfl-Deficient Mice 2013 ·Journal of Cerebral Blood Flow & Metabolism ·Ai-Ling Lin, Daniel Pulliam, Sathyaseelan S. Deepa, Jonathan J. Halloran, Stacy A. Hussong, Raquel R Burbank, (unknown), Yuhong Liu, Natalia Podlutskaya, Anuradha Soundararajan, Eric R. Muir, Timothy Q. Duong, Alex Bokov, Carlo Viscomi, Massimo Zeviani, Arlan Richardson, Holly Van Remmen, Peter T. Fox, Verónica Galván	28
13	The Effects of Cell Phone Conversations on the Attention and Memory of Bystanders 2013 ·PLoS ONE ·Verónica Galván, (unknown), (unknown)	16
14	Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease 2011 ·PLoS ONE ·Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart, Jayanta Debnath, Olivia Gorostiza, Dale E. Bredesen, Arlan Richardson, Randy Strong, Verónica Galván	2
15	Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease breakdown → 2010 ·PLoS ONE ·Patricia Spilman, Natalia Podlutskaya, Matthew J. Hart, Jayanta Debnath, Olivia Gorostiza, Dale E. Bredesen, Arlan Richardson, Randy Strong, Verónica Galván	807
16	In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP 2009 ·Free Radical Biology and Medicine ·D. Allan Butterfield, Verónica Galván, (unknown), Huidong Tang, Renã A. Sowell, Patricia Spilman, Joanna Fombonne, Olivia Gorostiza, Junli Zhang, Rukhsana Sultana, Dale E. Bredesen	166
17	Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: A role for early experience 2009 ·Behavioural Brain Research ·(unknown), Olivia Gorostiza, Huidong Tang, Dale E. Bredesen, Verónica Galván	20
18	Endogenous Neural Stem Cells in the Adult Brain 2007 ·Journal of Neuroimmune Pharmacology ·Kunlin Jin, Verónica Galván	42
19	Effect of neural precursor proliferation level on neurogenesis in rat brain during aging and after focal ischemia 2007 ·Neurobiology of Aging ·Huidong Tang, Yaoming Wang, Lin Xie, (unknown), Seok Joon Won, Verónica Galván, Kunlin Jin	33
20	Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat 2006 ·Brain Research ·Yaoming Wang, Verónica Galván, Olivia Gorostiza, (unknown), Kunlin Jin, David A. Greenberg	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact